OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+19.4%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$334M
AUM Growth
+$334M
(+16%)
Cap. Flow
+$20.1M
Cap. Flow
% of AUM
6.03%
Top 10 Holdings %
Top 10 Hldgs %
61.83%
Holding
47
New
7
Increased
16
Reduced
9
Closed
6
Top Buys
| 1 |
Karyopharm Therapeutics
KPTI
|
$6.24M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$5.52M |
| 3 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$5.33M |
| 4 |
Theravance Biopharma
TBPH
|
$4.98M |
| 5 |
IDEAYA Biosciences
IDYA
|
$2.8M |
Top Sells
| 1 |
Zentalis Pharmaceuticals
ZNTL
|
$3.37M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$3.23M |
| 3 |
Mersana Therapeutics
MRSN
|
$2.7M |
| 4 |
Fennec Pharmaceuticals
FENC
|
$2.61M |
| 5 |
BioAtla
BCAB
|
$2.16M |
Sector Composition
| 1 | Healthcare | 98.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THRX
26
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $4.33M | 1.3% |
488,100
-46,900
| -9% | -$416K |
|
|
EDAP
27
EDAP TMS
EDAP
$84.5M
| $4.23M | 1.27% |
382,400
+75,687
| +25% | +$838K |
|
28
Astria Therapeutics
ATXS
$349M
| $4.1M | 1.23% |
302,000
+40,297
| +15% | +$547K |
|
29
Liquidia Corp
LQDA
$2.38B
| $3.97M | 1.19% |
575,200
+15,200
| +3% | +$105K |
|
30
Fortress Biotech
FBIO
$76.8M
| $3.75M | 1.12% |
4,573,600
+2,523,600
| +123% | +$2.07M |
|
31
Phathom Pharmaceuticals
PHAT
$864M
| $3.54M | 1.06% |
496,000
+78,500
| +19% | +$560K |
|
32
Codexis
CDXS
$246M
| $3.11M | 0.93% |
750,000
-207,500
| -22% | -$859K |
|
33
Iovance Biotherapeutics
IOVA
$807M
| $2.57M | 0.77% |
+421,000
| New | +$2.57M |
|
34
Relay Therapeutics
RLAY
$619M
| $2.07M | 0.62% |
+125,500
| New | +$2.07M |
|
35
Kezar Life Sciences
KZR
$28.9M
| $1.96M | 0.59% |
+625,000
| New | +$1.96M |
|
36
Mineralys Therapeutics
MLYS
$1.03B
| $1.8M | 0.54% |
+115,000
| New | +$1.8M |
|
37
Stereotaxis
STXS
$261M
| $1.77M | 0.53% |
867,100
-317,900
| -27% | -$649K |
|
38
Trevi Therapeutics
TRVI
$883M
| $1.55M | 0.46% |
835,800
+350,800
| +72% | +$649K |
|
39
ProQR Therapeutics
PRQR
$237M
| $1.39M | 0.42% |
653,000
-807,000
| -55% | -$1.72M |
|
|
NYXH
40
Nyxoah
NYXH
$234M
| $430K | 0.13% |
+57,585
| New | +$430K |
|
41
Modular Medical
MODD
$39.9M
| $266K | 0.08% |
183,500
-61,500
| -25% | -$89.2K |
|
|
ALLK
42
DELISTED
Allakos
ALLK
| – | – |
-153,500
| Closed | -$1.29M |
|
|
43
BioAtla
BCAB
$26.7M
| – | – |
-261,800
| Closed | -$2.16M |
|
|
44
Fennec Pharmaceuticals
FENC
$247M
| – | – |
-272,200
| Closed | -$2.61M |
|
|
45
Mersana Therapeutics
MRSN
$36.5M
| – | – |
-460,000
| Closed | -$2.7M |
|
|
46
Zentalis Pharmaceuticals
ZNTL
$122M
| – | – |
-167,500
| Closed | -$3.37M |
|
|
WHWK
47
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| – | – |
-252,046
| Closed | -$3.23M |
|